All stock lists
Arcus Biosciences, Inc. (New York Stock Exchange:RCUS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
17.76-0.78 (-4.21%)
Insider Score
––Not scored
RCUS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
RCUS Stock Insider Trading Activity
RCUS stock’s insider trading shows 10 sales on the open market for an estimated $3.26M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Azoy Alexander Other | Option exercise | 2,827 | $15.44 | $43.65K | 7.1% | 42,408 | Aug 21, 2026 | — | Form 4 |
| Azoy Alexander Other | Sell | 2,827 | $30.00 | $84.81K | 6.7% | 39,581 | Aug 21, 2026 | — | Form 4 |
| Jaen Juan C. Other | Sell | 268 | $29.40 | $7.88K | 0.0% | 822,240 | Jul 10, 2026 | — | Form 4 |
| Jaen Juan C. Other | Sell | 19,799 | $28.61 | $566.41K | 2.4% | 822,508 | Jul 10, 2026 | — | Form 4 |
| Jaen Juan C. Other | Sell | 48,502 | $30.05 | $1.46M | 5.4% | 842,307 | Jul 9, 2026 | — | Form 4 |
| Jaen Juan C. Other | Sell | 6,431 | $29.66 | $190.74K | 0.7% | 890,809 | Jun 24, 2026 | — | Form 4 |
| Jaen Juan C. Other | Sell | 1,697 | $28.06 | $47.62K | 0.2% | 897,240 | Jun 23, 2026 | — | Form 4 |
| Jaen Juan C. Other | Sell | 14,067 | $27.69 | $389.52K | 1.5% | 898,937 | Jun 23, 2026 | — | Form 4 |
| Jaen Juan C. Other | Sell | 9,236 | $27.03 | $249.65K | 1.0% | 913,004 | Jun 22, 2026 | — | Form 4 |
| Tang Carolyn C. Other | Option exercise | 34,090 | $2.57 | $87.61K | 22.6% | 184,607 | Jun 11, 2026 | — | Form 4 |
| Lacey David L. Director | Award | 5,700 | — | — | 8.0% | 76,652 | Jun 11, 2026 | — | Form 4 |
| FALBERG KATHRYN E Director | Award | 5,700 | — | — | 14.8% | 44,300 | Jun 11, 2026 | — | Form 4 |
| Ribas Antoni Director | Award | 5,700 | — | — | 14.8% | 44,300 | Jun 11, 2026 | — | Form 4 |
| PERLMAN ANDREW J Director | Award | 5,700 | — | — | 13.4% | 48,325 | Jun 11, 2026 | — | Form 4 |
| Lambert Nicole Director | Award | 5,700 | — | — | 15.3% | 43,000 | Jun 11, 2026 | — | Form 4 |
| Machado Patrick Director | Award | 5,700 | — | — | 14.8% | 44,300 | Jun 11, 2026 | — | Form 4 |
| KANEKO YASUNORI Director | Award | 5,700 | — | — | 28.5% | 25,700 | Jun 11, 2026 | — | Form 4 |
| Azoy Alexander Other | Sell | 2,562 | $25.77 | $66.02K | 6.1% | 39,581 | Jun 1, 2026 | — | Form 4 |
| Goeltz II Robert C. CFO | Sell | 7,763 | $25.63 | $198.97K | 8.4% | 84,161 | May 11, 2026 | — | Form 4 |
| Azoy Alexander Other | Award | 21,050 | — | — | 114% | 39,581 | Jan 23, 2026 | — | Form 4 |
| Tang Carolyn C. Other | Award | 24,000 | — | — | 19.2% | 148,734 | Jan 23, 2026 | — | Form 4 |
| Markus Richard Other | Award | 24,000 | — | — | 36.6% | 89,647 | Jan 23, 2026 | — | Form 4 |
| Jaen Juan C. Other | Award | 31,000 | — | — | 9.0% | 377,012 | Jan 23, 2026 | — | Form 4 |
| Jarrett Jennifer COO | Award | 31,000 | — | — | 16.1% | 224,024 | Jan 23, 2026 | — | Form 4 |
| ROSEN TERRY J CEO | Award | 79,000 | — | — | 3.7% | 2,236,409 | Jan 23, 2026 | — | Form 4 |
| Goeltz II Robert C. CFO | Award | 24,000 | — | — | 35.3% | 91,924 | Jan 23, 2026 | — | Form 4 |
| ROSEN TERRY J CEO | Gift | 35,000 | — | — | 1.6% | 2,157,409 | Jan 8, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
- Option exercise (M) — Exercise or conversion of an exempt derivative
- Gift (G) — Bona fide gift
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.